Evolution of Molecular Generation Models in Drug Discovery
Journal of Medicinal Chemistry · 22.01.2026 · 69 (2) · 845-866
DOI: 10.1021/acs.jmedchem.5c03310 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 09.01.2026. Verfasst von Hao-Xiang Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan 610041, China. Hauptthemen laut MEDLINE: Drug Discovery, Models, Molecular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Molecular generative models (MGMs) are rapidly reshaping the landscape of drug discovery. To date, thousands of MGMs have been reported, some of which facilitate the design and optimization of molecules with the desired biological activities and pharmacological properties. In the context of drug discovery, we classify common MGMs into three primary categories: ligand-based molecular generation (LBMG), structure-based molecular generation (SBMG), and pharmacophore-based molecular generation (PBMG). This perspective discusses the principles underlying these MGMs, their evolution, and typical examples of LBMG, SBMG, and PBMG, along with their successful applications in drug discovery. Additionally, we discuss their respective advantages, limitations, and potential future research directions with the hope of promoting the continued development and application of MGMs in advancing drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan 610041, China.
- School of Pharmaceutical Sciences, Fudan University, National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201203, China.
- State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Children's Medicine Key Laboratory of Sichuan Province, Sichuan University, Chengdu, Sichuan 610041, China.
ORCID-Profile: Hao-Xiang Xu, Jian Peng, Ben-Gui Ye, Guo-Bo Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, H. X., Peng, J., Yu, J. L., Hong, X., Xiao, Y., Ye, B. G., & Li, G. B. (2026). Evolution of Molecular Generation Models in Drug Discovery. Journal of Medicinal Chemistry, 69(2), 845-866. https://doi.org/10.1021/acs.jmedchem.5c03310
Vancouver
Xu HX, Peng J, Yu JL, Hong X, Xiao Y, Ye BG, et al. Evolution of Molecular Generation Models in Drug Discovery. Journal of Medicinal Chemistry. 2026;69(2):845-866. doi:10.1021/acs.jmedchem.5c03310
BibTeX
@article{Xu2026,
author = {Xu, Hao-Xiang and Peng, Jian and Yu, Jun-Lin and Hong, Xuechuan and Xiao, Yuling and Ye, Ben-Gui and Li, Guo-Bo},
title = {Evolution of Molecular Generation Models in Drug Discovery},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {2},
pages = {845--866},
doi = {10.1021/acs.jmedchem.5c03310}
}
EUVIMED